Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jcrc.2020.11.004 http://scihub22266oqcxt.onion/10.1016/j.jcrc.2020.11.004 33220575!7664357!33220575     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Crit+Care 2021 ; 61 (ä): 221-226 Nephropedia Template TP {{tp|p=33220575|t=2021. Veno-venous extracorporeal membrane oxygenation allocation in the COVID-19 pandemic |pdf=|usr=}}{{33220575}} gab.com Text Veno-venous extracorporeal membrane oxygenation allocation in the COVID-19 pandemic JO: J Crit Care http://www.kidney.de/pget.php?&tw=1&pmid=33220575 #FOAvip Rapid global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resultant clinical illness, coronavirus disease 2019 (COVID-19), drove the World Health Organization to declare COVID-19 a pandemic. Veno-venous Extra-Corporeal Membrane Oxygenation (VV-ECMO) is an established therapy for management of patients demonstrating the most severe forms of hypoxemic respiratory failure from COVID-19. However, features of COVID-19 pathophysiology and necessary length of treatment present distinct challenges for utilization of VV-ECMO within the current healthcare emergency. In addition, growing allocation concerns due to capacity and cost present significant challenges. Ethical and legal aspects pertinent to triage of this resource-intensive, but potentially life-saving, therapy in the setting of the COVID-19 pandemic are reviewed here. Given considerations relevant to VV-ECMO use, additional emphasis has been placed on emerging hospital resource scarcity and disproportionate representation of healthcare workers among the ill. Considerations are also discussed surrounding withdrawal of VV-ECMO and the role for early communication as well as consultation from palliative care teams and local ethics committees. In discussing how to best manage these issues in the COVID-19 pandemic at present, we identify gaps in the literature and policy important to clinicians as this crisis continues. Twit Text FOAVip Veno-venous extracorporeal membrane oxygenation allocation in the COVID-19 pandemic ????J Crit Care http://www.kidney.de/pget.php?&tw=1&pmid=33220575 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33220575 #FOAvip English Wikipedia <ref>{{Cite pmid|33220575}}</ref> Veno-venous extracorporeal membrane oxygenation allocation in the COVID-19 pandemic #MMPMID33220575 Murugappan KR; Walsh DP; Mittel A; Sontag D; Shaefi S J Crit Care 2021[Feb]; 61 (ä): 221-226 PMID33220575show ga Rapid global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resultant clinical illness, coronavirus disease 2019 (COVID-19), drove the World Health Organization to declare COVID-19 a pandemic. Veno-venous Extra-Corporeal Membrane Oxygenation (VV-ECMO) is an established therapy for management of patients demonstrating the most severe forms of hypoxemic respiratory failure from COVID-19. However, features of COVID-19 pathophysiology and necessary length of treatment present distinct challenges for utilization of VV-ECMO within the current healthcare emergency. In addition, growing allocation concerns due to capacity and cost present significant challenges. Ethical and legal aspects pertinent to triage of this resource-intensive, but potentially life-saving, therapy in the setting of the COVID-19 pandemic are reviewed here. Given considerations relevant to VV-ECMO use, additional emphasis has been placed on emerging hospital resource scarcity and disproportionate representation of healthcare workers among the ill. Considerations are also discussed surrounding withdrawal of VV-ECMO and the role for early communication as well as consultation from palliative care teams and local ethics committees. In discussing how to best manage these issues in the COVID-19 pandemic at present, we identify gaps in the literature and policy important to clinicians as this crisis continues. |*Pandemics[MESH] |Academic Medical Centers[MESH] |COVID-19/complications/*therapy[MESH] |Ethics, Medical[MESH] |Extracorporeal Membrane Oxygenation/adverse effects/*methods[MESH] |Health Personnel[MESH] |Health Services Accessibility[MESH] |Humans[MESH] |Palliative Care[MESH] |Resource Allocation/*methods[MESH] |Respiratory Insufficiency/complications/*therapy[MESH]Veno-venous extracorporeal membrane oxygenation allocation in the COVI(epmc).pdf DeepDyve Pubget Overpricing